rheumatoid arthritis
FDA Approves Citrate-Free Formulation of Hyrimoz, a Biosimilar to Humira
The FDA approved a citrate-free high-concentration formulation of Hyrimoz injection, a biosimilar to Humira.
MARCH 31, 2023
FDA Warns of Possible Serious CV Events, Cancer Linked to Xeljanz
The FDA issued an alert concerning an increased risk for serious cardiovascular events and malignancies with the ...
FEBRUARY 6, 2021
Load more